MINTOR 2: Myocardial Infarction Triggers and Onset in Jordan Study 2

Sponsor
Jordan Collaborating Cardiology Group (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05992012
Collaborator
Cardiovascular Academy Group (Other)
1,000
1
27
37

Study Details

Study Description

Brief Summary

A previous study (MINTOR 1) found that 43% of ST elevation myocardial infarction (STEMI) patients in Jordan had a triggering events. Fifteen years later, with changing demographics and in the post covid-19 time, we believe that triggered acute myocardial infarction might have changed in incidence and nature of the triggering events.

Detailed Description

The onset of acute ST elevation myocardial infarction (STEMI) is a complex interplay of internal circadian factors and external physical and emotional triggers. These interactions may lead to rupture of an often nonocclusive vulnerable atherosclerotic coronary plaque with subsequent formation of an occlusive thrombus. The onset of MI has a distinct pattern, with peak incidence within the first few hours after awakening, on certain days of the week, and in the winter months. Physical and emotional stresses are important triggers of acute cardiovascular events including MI. Triggering events, internal changes, and external factors vary among different geographical, environmental, and ethnic regions. Life-style changes, pharmacotherapy, and psychologic interventions may potentially modify the response to, and protect against the effects of triggering events.

MINTOR 1 showed that 43% of 900+ Jordanians with STEMI were exposed to a physical or emotional triggers before the onset of the heart attack. We also fo0und that Friday was the day of the week that witnessed more MIs that other days of the week and that 55% of MIs occurred in the early morning hours.

We do not know if the frequency and types of triggers, onset time of MI, day with peak of MI incidence have changed over time in Jordan with changing population demographics, especially in the post Covid-19 times. We will also follow these patients fr 3 years for occurring of incident vascular events.

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
1000 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Myocardial Infarction Triggers and Onset in Jordan Study (MINTOR) 2
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Oct 1, 2025
Anticipated Study Completion Date :
Jan 1, 2026

Outcome Measures

Primary Outcome Measures

  1. Triggers of acute myocardial infarction [From date of study enrollment until the date of a documented exposure to a trigger, up to the time of discharge from the hospital (2-5 days).]

    Exposure to emotional of physical triggering events before the occurrence of the heart attack

  2. Time of onset of acute myocardial infarction [From date of study enrollment until the date of documenting the day and hour of onset of the heart attach, up to the time of discharge from the hospital (2-5 days)]

    Documenting the time of onset of the chest pain that marks the onset of the myocardial infarction (expressed as day of the week (MONDAY to SUNDAY) and time of the day (00:00 hr to 24:00 hr).

  3. Acute cardiovascular events [From date of study enrollment until the date of occurrence of the first cardiovascular event (described above) up to three years after study enrollment.]

    Occurrence of death from any cause, myocardial infarction, stroke, heart failure, repeat coronary revascularization (percutaneous or surgical).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Age 18 years and above.

  • Documented acute ST elevation myocardial infarction.

  • Willing to sign an informed consent.

  • Available contact numbers for a 3-year follow up

Exclusion Criteria:
  • Unwilling to sign an informed consent.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Istishari Hospital Amman Jordan 11888

Sponsors and Collaborators

  • Jordan Collaborating Cardiology Group
  • Cardiovascular Academy Group

Investigators

  • Study Director: Daria Jaara, MD, Istishari Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jordan Collaborating Cardiology Group
ClinicalTrials.gov Identifier:
NCT05992012
Other Study ID Numbers:
  • CVAG.MINTOR2.7AUG23
First Posted:
Aug 15, 2023
Last Update Posted:
Aug 15, 2023
Last Verified:
Aug 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jordan Collaborating Cardiology Group
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 15, 2023